Key terms
About CDXS
Codexis, Inc. is an enzyme engineering company, which engages in the development and sale of therapeutics. It operates through the Performance Enzymes and Novel Biotherapeutics segments. The Performance Enzymes segment commercializes CodeEvolver protein engineering technology platform and products in the pharmaceuticals market. The Novel Biotherapeutics segment targets new opportunities to discover and improve biotherapeutic drug candidates. Its products include screening kits and Codex HiFi Hot Start DNA Polymerase. The company was founded in January 2002 and is headquartered in Redwood City, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest CDXS news
Apr 11
7:11am ET
Codexis appoints Carole Cobb to strategic advisory board
Mar 01
11:04am ET
Biotech Alert: Searches spiking for these stocks today
Mar 01
7:48am ET
Piper Sandler Sticks to Their Buy Rating for Codexis (CDXS)
Mar 01
1:00am ET
A New Cause for Concern: Codexis Adds a New Corporate Activity and Growth Risk
Feb 29
9:55am ET
Codexis upgraded to Buy at Benchmark after Q4 revenue and 2024 guidance
Feb 29
9:34am ET
Codexis upgraded to Buy from Hold at Benchmark
Feb 29
8:19am ET
Stifel Nicolaus Keeps Their Buy Rating on Codexis (CDXS)
Feb 28
10:20pm ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Butterfly Network (BFLY) and Codexis (CDXS)
Feb 26
4:19pm ET
Codexis, Roche in licensing deal for newly engineered double-sranded DNA Ligase
Feb 26
9:06am ET
Craig-Hallum Gives a Buy Rating to Codexis (CDXS)
Feb 20
8:17am ET
Codexis appoints Damha, Lalonde to strategic advisory board
Feb 13
4:42pm ET
Codexis enters $40M loan facility agreement with Innovatus
Feb 13
4:35pm ET
Codexis Secures Strategic Financing to Support Growth Initiatives
Feb 02
8:50am ET
Analysts Offer Insights on Healthcare Companies: Codexis (CDXS) and Phathom Pharmaceuticals (PHAT)
Jan 22
3:50pm ET
Analysts Offer Insights on Healthcare Companies: Codexis (CDXS), Leap Therapeutics (LPTX) and Sutro Biopharma (STRO)
Jan 22
1:12pm ET
Piper Sandler Keeps Their Buy Rating on Codexis (CDXS)
No recent news articles are available for CDXS
No recent press releases are available for CDXS
CDXS Financials
Key terms
Ad Feedback
CDXS Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
CDXS Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
